Claris divests 80 pc stake in infusion biz for Rs 1,050 cr

Comments print
Agencies: New Delhi, Dec 07 2012, 21:23 IST
Drug.jpg
the deal, OPF President Ichiro Otsuka said the company is committed to being the best partner of both patients and healthcare professionals in the field of clinical nutrition, and together with Claris and Mitsui will contribute to the betterment of medical care in India.

As part of the deal, two of the out of the five plants of Claris would be transferred to joint venture firm – Claris- -Otsuka, the company said.

The JV will co-brand its products in India and across emerging markets utilising the manufacturing and marketing competence of Claris, it added.

Shares of Claris Lifesciences today closed at Rs 264.55 on the BSE, down 3.75 per cent from its previous close.

Ads by Google
   Previous | 1 | 2
Previous Story  Brother admits killing sister, former EastEnders actress Gemma McCluskie Next Story  Sebi to tighten oversight mechanism for brokers
Reader's Comments| Post a Comment

Be the first to comment.

Post your Comment

Your email address will not be published. Required fields are marked *

Name *
Email *
Message *
 
captcha
please enter the above characters in the box below